HTEC news

ROBO Global(R) Healthcare Technology and Innovation · Healthcare · North America · Digital Health

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

24/7 Wall St. · 28 Oct 2026, 22:00 UTC
Thermo Fisher Scientific Reaches $704 and a New 52-Week High
2.2% of HTEC
Benzinga · 26 Oct 2026, 17:27 UTC
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - Danaher (NYSE:DHR)
9.5% of HTEC
News-Medical.net · 28 Oct 2026, 17:31 UTC
Hot-melt extrusion in pharmaceutical implant manufacturing
2.2% of HTEC
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
2.1% of HTEC
Where to buy HTEC
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Yahoo! Finance · 28 Oct 2026, 22:09 UTC
Apple Stock And Other Quality Growth Names For Higher Rates
1.8% of HTEC
Investing.com · 28 Oct 2026, 14:08 UTC
Why is Twist Bioscience stock surging today? By Investing.com
2.2% of HTEC
Where to buy HTEC
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Morningstar · 28 Oct 2026, 14:15 UTC
TMO - Thermo Fisher Scientific Inc Analysis
2.2% of HTEC
Investing.com · 28 Oct 2026, 20:12 UTC
Mizuho raises AxoGen stock price target to $65 on growth outlook By Investing.com
1.8% of HTEC
wallstreet:online · 28 Oct 2026, 12:05 UTC
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
2.2% of HTEC
Financial Post · 28 Oct 2026, 00:00 UTC
How Brands Do Agentic Marketing Today: Lessons From the 2026 Contentstack Experience Award Winners
1.6% of HTEC
Benzinga · 28 Oct 2026, 18:42 UTC
Order Flow Analysis Highlights Technology And Health Care
1.7% of HTEC
Aol · 28 Oct 2026, 17:44 UTC
Boston Scientific (BSX) Q3 2026 Earnings Call Transcript
1.7% of HTEC
Investing.com · 28 Oct 2026, 22:30 UTC
Intuitive Surgical EVP Mark Brosius sells $82,043 in company stock By Investing.com
1.5% of HTEC
Seeking Alpha · 28 Oct 2026, 17:11 UTC
Boston Scientific anticipates Q4 2026 organic revenue down 3% to down 1% and adjusted EPS $0.77-$0.79 amid cyber and EP/WATCHMAN pressure (NYSE:BSX) | Seeking Alpha
1.7% of HTEC
Seeking Alpha · 28 Oct 2026, 17:09 UTC
Boston Scientific Corporation (BSX) Q3 2026 Earnings Call Transcript | Seeking Alpha
1.7% of HTEC
Investing.com · 28 Oct 2026, 15:42 UTC
Incyte earnings up next: Analysts eye loss amid pipeline gains By Investing.com
1.8% of HTEC
wallstreet:online · 28 Oct 2026, 20:10 UTC
CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
1.6% of HTEC
Seeking Alpha · 28 Oct 2026, 11:43 UTC
Regeneron Earnings Preview: Dupixent Is Booming, But It's Still Overvalued (NASDAQ:REGN) | Seeking Alpha
2.0% of HTEC
Market Screener · 28 Oct 2026, 14:41 UTC
Adagene Inc. Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte?S Inca33890 in Patients with Microsatellite Stable Colorectal Cancer
1.8% of HTEC
The Wall Street Journal · 28 Oct 2026, 15:37 UTC
Boston Scientific Stock Drops on Sales Softness
1.7% of HTEC

HTEC news

Where to buy HTEC

Where to buy HTEC